{"entity":{"type":"insider","cik":"0001692961","url":"/insider/0001692961","json_url":"/insider/0001692961.json","name":"GRAY WILLIAM GARRETT","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":14,"first":"2020-05-22","last":"2025-04-03","span_basis":"filed_date"},"name_variants":[{"name":"GRAY WILLIAM GARRETT","source":"filing","n_filings":14,"first_seen":"2020-05-22","last_seen":"2025-04-03"}],"transactions":[{"id":4547952,"accession":"0001104659-25-031811","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-031811","line_url":"/filing/0001104659-25-031811#line-1","is_derivative":false,"issuer_cik":"0001651407","issuer_name":"Checkpoint Therapeutics, Inc.","issuer_ticker":"CKPT","issuer_name_source":null,"issuer_url":"/issuer/0001651407","owner_cik":"0001692961","owner_name":"GRAY WILLIAM GARRETT","owner_display_name":"GRAY WILLIAM GARRETT","owner_url":"/insider/0001692961","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12322.0,"shares_display":"12,322","price_per_share":4.05,"price_display":"4.05","price_state":"stated","total_value":49904.1,"total_display":"49,904.10","total_whole":"49,904","shares_owned_after":1446322.0,"shares_owned_after_display":"1,446,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-01","filed_date":"2025-04-03","scope":"insider"},{"id":4665551,"accession":"0001104659-25-010662","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-010662","line_url":"/filing/0001104659-25-010662#line-1","is_derivative":false,"issuer_cik":"0001651407","issuer_name":"Checkpoint Therapeutics, Inc.","issuer_ticker":"CKPT","issuer_name_source":null,"issuer_url":"/issuer/0001651407","owner_cik":"0001692961","owner_name":"GRAY WILLIAM GARRETT","owner_display_name":"GRAY WILLIAM GARRETT","owner_url":"/insider/0001692961","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":74110.0,"shares_display":"74,110","price_per_share":3.67,"price_display":"3.67","price_state":"stated","total_value":271983.7,"total_display":"271,983.70","total_whole":"271,984","shares_owned_after":1458644.0,"shares_owned_after_display":"1,458,644","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-06","filed_date":"2025-02-07","scope":"insider"},{"id":2206911,"accession":"0001104659-24-130962","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-130962","line_url":"/filing/0001104659-24-130962#line-1","is_derivative":false,"issuer_cik":"0001651407","issuer_name":"Checkpoint Therapeutics, Inc.","issuer_ticker":"CKPT","issuer_name_source":null,"issuer_url":"/issuer/0001651407","owner_cik":"0001692961","owner_name":"GRAY WILLIAM GARRETT","owner_display_name":"GRAY WILLIAM GARRETT","owner_url":"/insider/0001692961","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":268432.0,"shares_display":"268,432","price_per_share":4.01,"price_display":"4.01","price_state":"stated","total_value":1076412.32,"total_display":"1,076,412.32","total_whole":"1,076,412","shares_owned_after":1032754.0,"shares_owned_after_display":"1,032,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-18","filed_date":"2024-12-20","scope":"insider"},{"id":2778861,"accession":"0001104659-24-076441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-076441","line_url":"/filing/0001104659-24-076441#line-1","is_derivative":false,"issuer_cik":"0001651407","issuer_name":"Checkpoint Therapeutics, Inc.","issuer_ticker":"CKPT","issuer_name_source":null,"issuer_url":"/issuer/0001651407","owner_cik":"0001692961","owner_name":"GRAY WILLIAM GARRETT","owner_display_name":"GRAY WILLIAM GARRETT","owner_url":"/insider/0001692961","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13038.0,"shares_display":"13,038","price_per_share":2.06,"price_display":"2.06","price_state":"stated","total_value":26858.28,"total_display":"26,858.28","total_whole":"26,858","shares_owned_after":672186.0,"shares_owned_after_display":"672,186","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-26","filed_date":"2024-06-28","scope":"insider"},{"id":2146544,"accession":"0001104659-24-030148","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-030148","line_url":"/filing/0001104659-24-030148#line-1","is_derivative":false,"issuer_cik":"0001651407","issuer_name":"Checkpoint Therapeutics, Inc.","issuer_ticker":"CKPT","issuer_name_source":null,"issuer_url":"/issuer/0001651407","owner_cik":"0001692961","owner_name":"GRAY WILLIAM GARRETT","owner_display_name":"GRAY WILLIAM GARRETT","owner_url":"/insider/0001692961","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2035.0,"shares_display":"2,035","price_per_share":2.07,"price_display":"2.07","price_state":"stated","total_value":4212.45,"total_display":"4,212.45","total_whole":"4,212","shares_owned_after":145224.0,"shares_owned_after_display":"145,224","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-28","filed_date":"2024-03-01","scope":"insider"},{"id":2128774,"accession":"0001104659-24-010268","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-010268","line_url":"/filing/0001104659-24-010268#line-1","is_derivative":false,"issuer_cik":"0001651407","issuer_name":"Checkpoint Therapeutics, Inc.","issuer_ticker":"CKPT","issuer_name_source":null,"issuer_url":"/issuer/0001651407","owner_cik":"0001692961","owner_name":"GRAY WILLIAM GARRETT","owner_display_name":"GRAY WILLIAM GARRETT","owner_url":"/insider/0001692961","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4115.0,"shares_display":"4,115","price_per_share":1.95,"price_display":"1.95","price_state":"stated","total_value":8024.25,"total_display":"8,024.25","total_whole":"8,024","shares_owned_after":147259.0,"shares_owned_after_display":"147,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-02","scope":"insider"},{"id":8052173,"accession":"0001104659-23-028602","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-23-028602","line_url":"/filing/0001104659-23-028602#line-3","is_derivative":false,"issuer_cik":"0001651407","issuer_name":"Checkpoint Therapeutics, Inc.","issuer_ticker":"CKPT","issuer_name_source":null,"issuer_url":"/issuer/0001651407","owner_cik":"0001692961","owner_name":"GRAY WILLIAM GARRETT","owner_display_name":"GRAY WILLIAM GARRETT","owner_url":"/insider/0001692961","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3591.0,"shares_display":"3,591","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":17955.0,"total_display":"17,955.00","total_whole":"17,955","shares_owned_after":51374.0,"shares_owned_after_display":"51,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-03","scope":"insider"},{"id":8052169,"accession":"0001104659-23-028602","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-028602","line_url":"/filing/0001104659-23-028602#line-2","is_derivative":false,"issuer_cik":"0001651407","issuer_name":"Checkpoint Therapeutics, Inc.","issuer_ticker":"CKPT","issuer_name_source":null,"issuer_url":"/issuer/0001651407","owner_cik":"0001692961","owner_name":"GRAY WILLIAM GARRETT","owner_display_name":"GRAY WILLIAM GARRETT","owner_url":"/insider/0001692961","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1914.0,"shares_display":"1,914","price_per_share":4.66,"price_display":"4.66","price_state":"stated","total_value":8919.24,"total_display":"8,919.24","total_whole":"8,919","shares_owned_after":47465.0,"shares_owned_after_display":"47,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-27","filed_date":"2023-03-03","scope":"insider"},{"id":8697042,"accession":"0001104659-23-010772","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-010772","line_url":"/filing/0001104659-23-010772#line-1","is_derivative":false,"issuer_cik":"0001651407","issuer_name":"Checkpoint Therapeutics, Inc.","issuer_ticker":"CKPT","issuer_name_source":null,"issuer_url":"/issuer/0001651407","owner_cik":"0001692961","owner_name":"GRAY WILLIAM GARRETT","owner_display_name":"GRAY WILLIAM GARRETT","owner_url":"/insider/0001692961","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3154.0,"shares_display":"3,154","price_per_share":4.79,"price_display":"4.79","price_state":"stated","total_value":15107.66,"total_display":"15,107.66","total_whole":"15,108","shares_owned_after":49379.0,"shares_owned_after_display":"49,379","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-03","scope":"insider"},{"id":8219897,"accession":"0001104659-23-003530","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-003530","line_url":"/filing/0001104659-23-003530#line-1","is_derivative":false,"issuer_cik":"0001651407","issuer_name":"Checkpoint Therapeutics, Inc.","issuer_ticker":"CKPT","issuer_name_source":null,"issuer_url":"/issuer/0001651407","owner_cik":"0001692961","owner_name":"GRAY WILLIAM GARRETT","owner_display_name":"GRAY WILLIAM GARRETT","owner_url":"/insider/0001692961","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1858.0,"shares_display":"1,858","price_per_share":6.749,"price_display":"6.75","price_state":"stated","total_value":12539.642,"total_display":"12,539.64","total_whole":"12,540","shares_owned_after":52533.0,"shares_owned_after_display":"52,533","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-10","filed_date":"2023-01-12","scope":"insider"},{"id":6147059,"accession":"0001104659-22-033018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-033018","line_url":"/filing/0001104659-22-033018#line-1","is_derivative":false,"issuer_cik":"0001651407","issuer_name":"Checkpoint Therapeutics, Inc.","issuer_ticker":"CKPT","issuer_name_source":null,"issuer_url":"/issuer/0001651407","owner_cik":"0001692961","owner_name":"GRAY WILLIAM GARRETT","owner_display_name":"GRAY WILLIAM GARRETT","owner_url":"/insider/0001692961","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38197.0,"shares_display":"38,197","price_per_share":1.893,"price_display":"1.89","price_state":"stated","total_value":72306.921,"total_display":"72,306.92","total_whole":"72,307","shares_owned_after":543910.0,"shares_owned_after_display":"543,910","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-10","filed_date":"2022-03-11","scope":"insider"},{"id":6717968,"accession":"0001104659-22-010998","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-010998","line_url":"/filing/0001104659-22-010998#line-2","is_derivative":false,"issuer_cik":"0001651407","issuer_name":"Checkpoint Therapeutics, Inc.","issuer_ticker":"CKPT","issuer_name_source":null,"issuer_url":"/issuer/0001651407","owner_cik":"0001692961","owner_name":"GRAY WILLIAM GARRETT","owner_display_name":"GRAY WILLIAM GARRETT","owner_url":"/insider/0001692961","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37063.0,"shares_display":"37,063","price_per_share":2.508,"price_display":"2.51","price_state":"stated","total_value":92954.004,"total_display":"92,954.00","total_whole":"92,954","shares_owned_after":582107.0,"shares_owned_after_display":"582,107","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-01","filed_date":"2022-02-02","scope":"insider"},{"id":4616237,"accession":"0001104659-21-013179","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-013179","line_url":"/filing/0001104659-21-013179#line-1","is_derivative":false,"issuer_cik":"0001651407","issuer_name":"Checkpoint Therapeutics, Inc.","issuer_ticker":"CKPT","issuer_name_source":null,"issuer_url":"/issuer/0001651407","owner_cik":"0001692961","owner_name":"GRAY WILLIAM GARRETT","owner_display_name":"GRAY WILLIAM GARRETT","owner_url":"/insider/0001692961","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26320.0,"shares_display":"26,320","price_per_share":3.6595,"price_display":"3.66","price_state":"stated","total_value":96318.04,"total_display":"96,318.04","total_whole":"96,318","shares_owned_after":482170.0,"shares_owned_after_display":"482,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-04","filed_date":"2021-02-05","scope":"insider"},{"id":3244750,"accession":"0001104659-20-139333","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-139333","line_url":"/filing/0001104659-20-139333#line-1","is_derivative":false,"issuer_cik":"0001651407","issuer_name":"Checkpoint Therapeutics, Inc.","issuer_ticker":"CKPT","issuer_name_source":null,"issuer_url":"/issuer/0001651407","owner_cik":"0001692961","owner_name":"GRAY WILLIAM GARRETT","owner_display_name":"GRAY WILLIAM GARRETT","owner_url":"/insider/0001692961","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2406.0,"shares_display":"2,406","price_per_share":2.7899,"price_display":"2.79","price_state":"stated","total_value":6712.4994,"total_display":"6,712.50","total_whole":"6,712","shares_owned_after":357490.0,"shares_owned_after_display":"357,490","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-22","filed_date":"2020-12-23","scope":"insider"},{"id":3243965,"accession":"0001104659-20-065429","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-065429","line_url":"/filing/0001104659-20-065429#line-1","is_derivative":false,"issuer_cik":"0001651407","issuer_name":"Checkpoint Therapeutics, Inc.","issuer_ticker":"CKPT","issuer_name_source":null,"issuer_url":"/issuer/0001651407","owner_cik":"0001692961","owner_name":"GRAY WILLIAM GARRETT","owner_display_name":"GRAY WILLIAM GARRETT","owner_url":"/insider/0001692961","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17104.0,"shares_display":"17,104","price_per_share":1.995,"price_display":"2.00","price_state":"stated","total_value":34122.48,"total_display":"34,122.48","total_whole":"34,122","shares_owned_after":359896.0,"shares_owned_after_display":"359,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-21","filed_date":"2020-05-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001651407","name":"Checkpoint Therapeutics, Inc.","url":"/issuer/0001651407","role":"Officer (Chief Financial Officer)","n_filings":14,"first_seen":"2020-05-22","last_seen":"2025-04-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001692961","retrieved_at":"2026-08-25T18:07:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}